Furthermore, the VEGF neutralizing antibody B20 reduced tumor size and lung metastases in ERO1-devoid xenograft mouse models of aggressive breast tumors, whereas in the WT counterpart this treatment had scant effects (Fig. 8). The gene discussed is VEGFA; the disease is breast neoplasm.